Literature DB >> 7286968

Lymphomas and pseudolymphomas of the alimentary tract. An immunohistochemical study with clinicopathologic correlations.

P Saraga, J Hurlimann, L Ozzello.   

Abstract

One hundred one lymphoproliferative lesions of the gastrointestinal tract (66 malignant lymphomas, 20 pseudolymphomas, and 5 borderline lesions) were reviewed. The pathologic features were compared to the clinical findings, with reference to differential diagnosis and prognosis. Special attention was paid to immunohistochemical features. The gross appearance was diagnostic in only a limited number of cases. Endoscopic biopsy alone was also of limited value because only a diagnosis of probability could be made in several cases. In most of them the definitive diagnosis had to be based on histologic examination of the resected specimen. Immunohistochemical examination was found to be very useful as an ancillary diagnostic technique. Malignant lymphomas displayed either cytoplasmic immunoglobulins with a monoclonal pattern (47.1 per cent) or a negative reaction, whereas the pseudolymphomas were generally characterized by polyclonal immunoglobulins. Ninety per cent of malignant lymphomas with cytoplasmic immunoglobulins contained lambda chains. The survival probability was found to be related to the size of the lesion, the depth of infiltration, and the immunohistochemical characteristics of the tumors. The histologic type of the lymphomas was of limited value as a predictor of prognosis in the present series.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286968     DOI: 10.1016/s0046-8177(81)80173-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Molecular-genetic analysis of ocular adnexal benign lymphoid hyperplasias by a two-step polymerase-chain-reaction.

Authors:  Y Takano; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Gastric "pseudolymphoma" with restricted light chain expression in a patient with obscure gastrointestinal blood loss.

Authors:  H Schulman; J Sickel; M S Kleinman; J T Adams
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

3.  Malignant lymphoma of the gastrointestinal tract and mesentery. A clinico-pathologic study of the significance of histologic classification. NHL Study Group of the Comprehensive Cancer Center West.

Authors:  J H van Krieken; R Otter; J Hermans; K van Groningen; P J Spaander; M M van de Sandt; J F Keuning; P M Kluin
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

4.  Pseudolymphoma of the jejunum.

Authors:  H Gudjonsson; M Jones; E L Krawitt; M D Kaye
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

5.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

6.  Gastric pseudolymphoma. A challenging clinical problem.

Authors:  R K Orr; J R Lininger; W Lawrence
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

7.  Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach.

Authors:  J K Chan; C S Ng; P G Isaacson
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

8.  Lymphoid stromal reaction in gastrointestinal lymphomas: immunohistochemical study of 14 cases.

Authors:  A Jarry; N Brousse; A Souque; J Barge; G Molas; F Potet
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

9.  Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression.

Authors:  D P LeBrun; O W Kamel; M L Cleary; R F Dorfman; R A Warnke
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

10.  Primary gastrointestinal lymphoma in childhood (up to 18 years of age). A morphological, immunohistochemical and clinical study.

Authors:  H Takahashi; M L Hansmann
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.